Maggot Debridement Market To Reach $25.7 Million By 2030

Maggot Debridement Market Growth & Trends

The global maggot debridement market size is estimated to reach USD 25.7 million by 2030, registering to grow at a CAGR of 10.3% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising investment in research and development, growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.

In the recent past, there has been a rise in the number of surgical procedures across the globe. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. The incidence of infectious and non-communicable diseases has increased over the past few decades.

This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rising prevalence of food-borne diseases. An unhealthy lifestyle, lack of physical activity, alcohol abuse, and smoking are some of the major factors contributing to the rising prevalence of the abovementioned diseases. According to CDC estimates, in 2017, more than 100.0 million people were living with diabetes in the U.S.

Type II diabetes is the most common type of diabetes and 90.0% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires wound debridement and surgical intervention to prevent foot amputation. Thus, a rising number of chronic wounds are anticipated to increase the demand for maggot debridement.

 Request a free sample copy or view report summary: Maggot Debridement Market Report

Maggot Debridement Market Report Highlights

• The biobags segment dominated the market with the largest revenue share of 76.5% in 2024 owing to its ease of use, which has proven effective in promoting wound healing.

• The chronic wounds segment dominated the market and accounted for the largest revenue share of 59.9% in 2024, largely due to a rise in chronic wounds, such as diabetic foot ulcers, arthritis, and pressure ulcers, which are more common in older people and individuals with comorbidities such as diabetes and peripheral vascular diseases.

• Hospitals dominated the market and accounted for the largest revenue share of 45.4% in 2024, driven by their critical role in providing comprehensive wound care for patients with chronic, non-healing wounds and severe tissue damage.

Maggot Debridement Market Segmentation

Grand View Research has segmented the global maggot debridement market based on administration, application, end-use, and region:

Maggot Debridement Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Loose Larva

• Biobags

Maggot Debridement Application Outlook (Revenue, USD Million, 2018 - 2030)

• Acute Wounds

  • Surgical & Traumatic Wounds

  • Burns

• Chronic Wounds

  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Venous Leg Ulcers

  • Other Chronic Wounds

Maggot Debridement End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

• Clinics

• Wound Care Centers

• Others

Maggot Debridement Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Maggot Debridement Market

• BioMonde

• Monarch Labs

• Mega Pharma (Pvt) Ltd.

• Smith & Nephew

• Coloplast

• B. Braun Melsungen AG

• Mölnlycke Healthcare

• Lohmann & Rauscher 0

• Arobella Medical